Enkefalos Biosciences, Inc. — Form D
Enkefalos Biosciences, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-17. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-17
- Form: D
- Accession: 0001883300-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.5M
- Remaining: $1.5M
- Investors: 9
- Date of first sale: 2021-09-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413762
Issuer
- Name: Enkefalos Biosciences, Inc.
- CIK: 0001883300
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 10929 TECHNOLOGY PLACE, SAN DIEGO, CA, 92127
- Phone: (858) 346-6300
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Duncan McGregor | Director | San Diego, CA |
| Vaughn Smider | Director | San Diego, CA |
| Wei Zhao | Director | San Diego, CA |
| Duncan McGregor | Executive Officer | San Diego, CA |
| Vaughn Smider | Executive Officer | San Diego, CA |
More